Literature DB >> 20889361

Adenosine, inflammation pathways and therapeutic challenges.

Balázs Csóka, György Haskó.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 20889361     DOI： 10.1016/j.jbspin.2010.08.010

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  8 in total

1.  Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.

Authors:  Caglar Cekic; Yuan-Ji Day; Duygu Sag; Joel Linden
Journal:  Cancer Res       Date:  2014-11-06       Impact factor: 12.701

2.  Protective effect of chronic caffeine intake on gene expression of brain derived neurotrophic factor signaling and the immunoreactivity of glial fibrillary acidic protein and Ki-67 in Alzheimer's disease.

Authors:  Fatma M Ghoneim; Hanaa A Khalaf; Ayman Z Elsamanoudy; Salwa M Abo El-Khair; Ahmed M N Helaly; El-Hassanin M Mahmoud; Saad H Elshafey
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 3.  Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.

Authors:  Marla Rivera-Oliver; Manuel Díaz-Ríos
Journal:  Life Sci       Date:  2014-02-13       Impact factor: 5.037

4.  A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release.

Authors:  Katia Varani; Melissa Padovan; Fabrizio Vincenzi; Martina Targa; Francesco Trotta; Marcello Govoni; Pier Andrea Borea
Journal:  Arthritis Res Ther       Date:  2011-12-06       Impact factor: 5.156

5.  Adenosine A(2A) Receptor and IL-10 in Peripheral Blood Mononuclear Cells of Patients with Mild Cognitive Impairment.

Authors:  Beatrice Arosio; Luigina Mastronardi; Cristina Gussago; Paola Nicolini; Alessandra Casè; Eleonora Ziglioli; Luigi Bergamaschini
Journal:  Int J Alzheimers Dis       Date:  2011-05-10

6.  The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists?

Authors:  Rubina Marzagalli; Alessandro Castorina
Journal:  Neural Regen Res       Date:  2015-02       Impact factor: 5.135

7.  Ecto-5'-nucleotidase (CD73) attenuates inflammation after spinal cord injury by promoting macrophages/microglia M2 polarization in mice.

Authors:  Shun Xu; Wei Zhu; Minghao Shao; Fan Zhang; Ji Guo; Haocheng Xu; Jianyuan Jiang; Xiaosheng Ma; Xinlei Xia; Xiuling Zhi; Ping Zhou; Feizhou Lu
Journal:  J Neuroinflammation       Date:  2018-05-22       Impact factor: 8.322

8.  CD73 alleviates GSDMD-mediated microglia pyroptosis in spinal cord injury through PI3K/AKT/Foxo1 signaling.

Authors:  Shun Xu; Jin Wang; Junjie Zhong; Minghao Shao; Jianyuan Jiang; Jian Song; Wei Zhu; Fan Zhang; Haocheng Xu; Guangyu Xu; Yuxuan Zhang; Xiaosheng Ma; Feizhou Lyu
Journal:  Clin Transl Med       Date:  2021-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.